Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 5:17 p.m.

/zigman2/quotes/206805265/composite

$

6.80

Change

0.00 0.00%

Volume

Volume 1,625

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 6.82

$ 6.80

Change

-0.02 -0.29%

Day low

Day high

$6.75

$6.96

Open

52 week low

52 week high

$5.40

$12.99

Open

Andrew R. Boll

Founder of Eton Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc., Andrew R. Boll is an entrepreneur who presently holds the position of Chief Financial Officer & Secretary at Harrow Health, Inc. He is also Member of CFA Institute, Member of Institute of Management Accountants, Inc. and Member of Cfa Society San Diego.

In the past he held the position of Executive Director at Eton Pharmaceuticals, Inc. and Director at Melt Pharmaceuticals, Inc.

Andrew R. Boll received an undergraduate degree from Huron University.

Transactions

Date Shares Transaction Value
02/19/2022 20,605   Derivative/Non-derivative trans. at $7.87 per share. 162,162
02/19/2022 50,000   Derivative/Non-derivative trans. at $0 per share. 0
04/25/2021 49,832   Derivative/Non-derivative trans. at $8.26 per share. 411,613
04/25/2021 127,500   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2021 7,500   Derivative/Non-derivative trans. at $7.68 per share. 57,600
02/25/2021 30,000   Derivative/Non-derivative trans. at $0 per share. 0
11/22/2019 39,000   69,810
02/01/2018 30,000   Derivative/Non-derivative trans. at $1.83 per share. 54,900

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence van Horn
Independent Director
Mr. Perry J. Sternberg
Independent Director
Dr. Marty Makary
Independent Director
Link to MarketWatch's Slice.